| 000 | 02857nam a22002417a 4500 | ||
|---|---|---|---|
| 999 |
_c24941 _d24941 |
||
| 003 | OSt | ||
| 005 | 20190729073618.0 | ||
| 008 | 190721b ||||| |||| 00| 0 eng d | ||
| 040 | _cMSA | ||
| 082 | _a615.5 | ||
| 100 | _aAhmed Yahia Abas 151465 | ||
| 245 | _aDrug Prescribing Pattern in Intensive Care Unit of Al-Moalmeen Hospital in Egypt // GP // Dr. AbdelHamid El-Hawary // T.A. Salma Ayman (2018 - 2019) | ||
| 260 |
_aGiza: _bMSA, _c2019 |
||
| 500 | _aPharmacy - Clinical Pharmacy | ||
| 520 | 3 | _aThe intensive care unit is a special setting in hospitals where patients with severe, life-threating conditions are admitted, these patients mostly suffer from serious infections among other conditions which increases the mortality, morbidity and cost of hospitalization. The presented study was conducted to assess the drug utilization pattern mostly concerning the antibiotics prescription in the ICU. Aim is to Assess the treatment outcome specially for different combined therapies used for the treatment of gram-negative bacterial infections in the ICU and degree of improvement and period of staying in the ICU. Materials and Methods Retrospective study conducted in Intensive Care Unit of Al-Moalmeen Hospital. Analysis conducted on 54 cases admitted to ICU in six months. The data included: Age, Diagnosis, Vital signs, Treatment plan, and the outcome. APACHE Score was used to measure disease severity. Inclusion criteria: Patients with gram-negative bacteria infection from sputum, blood, and urine cultures. Exclusion criteria: Patients with Glasgow coma scale less than 9, End-stage metastatic malignant cancer patients, patients with APACHE II score more than 34, ventilated patients upon admission. The data analyzed by performing statistics on “Graph Pad Prism”. Results: Total 54 cases showed 62-gram negative bacteria cultures; 9 blood, 28 urine and 15 sputum cultures, also 10 swabs. These 62-cultures showed 31 cases E-coli, 14 cases klebsiella, 11 pseudomonas, and 6 cases Acinetobacter. 40 out 62 microorganisms treated with monotherapy including (Meronem/Forutm/Maixpime/Rocephin/Tazocin). 22 out 62 microorganisms treated with combined therapy including (Meropenem/Tavanic, Meronem/Ciprofloxacin, Meronem/Tigacylcine, Maxipime / Tavanic, Colistin/Gentamycin, and Ciprofloxacin /Amikin). Treatment with antibiotics monotherapy and combined therapy, empirical and targeted antibiotics therapy and Meronem antibiotic monotherapy and combined therapy didn’t show significant differences regarding mortality and survival rates. | |
| 650 | _aDrug Prescribing | ||
| 650 | _aDrug utilization | ||
| 700 | _aNoran Mansour Boraik 15108 | ||
| 700 | _aOmar Mohamed Nagy 151493 | ||
| 700 | _aSamah Mohamed Hussien 153533 | ||
| 856 |
_uhttps://qrgo.page.link/yWFh9 _zFULL TEXT PRESS HERE |
||
| 942 |
_2ddc _cD.GP |
||